The Europe and Canada (EUCAN) Business Unit operates across 37 countries and is headquartered in Zurich, Switzerland. The EUCAN Business Unit focuses on delivering life-transforming treatments in the therapy areas of Rare Metabolic Diseases, Gastroenterology, Neuroscience, Plasma-Derived Therapies and Oncology.
Takeda focuses on developing and delivering life changing treatment for diseases with the highest unmet, striving to provide better health for people and a better future for our planet. Our core values and philosophy are focused on integrity, fairness, honesty and perseverance and guide us in the way we conduct business and build our relationships with society – globally and in our local communities.
We aspire to transform lives by putting the patient first in how we make decisions and collaborate across the healthcare ecosystem. We develop meaningful scientific partnerships and value-based solutions with healthcare providers to enhance the standard of patient care. The EUCAN region contains a diversity of health systems, and we work closely with healthcare professionals, policy makers and patient organisations in each country to provide access to treatments and health education for all patients, no matter where they live.
We aspire to provide an exceptional employee experience by empowering and enabling our people to fulfil their potential. We consider diversity, equity, and inclusion a critical part of our continued success. We hold ourselves accountable for welcoming diversity of thought, fostering a speak-up culture, and embracing an agile way of working to create an enriching and customized experience for all employees wherever they are in their career journey.
We aim to innovate in the area of digital technology through strategic collaborations working to improve patient outcomes, increase disease awareness and better understand the voice of patients, their families and their care providers.
Thurgauerstrasse 130, 8152 Glattpark-Opfikon (Zurich), Switzerland
+41 44 555 10 00